Cutler Group LP Rocket Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$26.16 - $30.74 $209,280 - $245,920	8,000 New	8,000 $2,000
Q3 2023 Nov 07, 2023	BUY	$15.07 - $24.05 $4,521 - $7,215	300 New	300 $0
Q4 2021 Jan 18, 2022	SELL	$21.52 - $36.02 $17,216 - $28,816	-800 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$27.42 - $48.97 $82,260 - $146,910	-3,000 Reduced 78.95%	800 $0
Q2 2021 Jul 19, 2021	BUY	$39.41 - $47.25 $19,705 - $23,625	500 Added 15.15%	3,800 $13,000
Q1 2021 Apr 26, 2021	BUY	$43.34 - $65.91 $130,020 - $197,730	3,000 Added 1000.0%	3,300 $4,000
Q4 2020 Jan 21, 2021	BUY	$23.3 - $59.57 $6,990 - $17,871	300 New	300 $5,000

210

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $843M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.